A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Summary
Third Opinion Trial Synopsis:
This study wants to find out how well teclistamab works at the recommended Phase 2 dose.
This study wants to find out how well teclistamab works at the recommended Phase 2 dose.
*Third Opinion AI Generated Synopsis
Trial Summary
The purpose of this study is to evaluate the efficacy of teclistamab at the recommended Phase 2 dose (RP2D).
The purpose of this study is to evaluate the efficacy of teclistamab at the recommended Phase 2 dose (RP2D).
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts:
